Stock listing
A0D9T1 Stock Price, News, Filings & Events — Dexcom, Inc.
Selected listing: A0D9T1 · LS · EUR · DE
This page tracks Dexcom, Inc.'s A0D9T1:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A0D9T1:LS. A0D9T1:LS is the stock-level entry point for investors researching Dexcom, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Dexcom, Inc. (Ticker: DXCM) is a public company based in America, specializing in continuous glucose monitoring systems for diabetes management. With a market capitalization of approximately $27.6 billion, Dexcom is recognized for its innovative technology that helps improve the lives of individuals with diabetes. The company focuses on providing real-time glucose data to empower users in their health management.
- Ticker
- A0D9T1:LS
- Asset type
- Stock
- Market cap
- $34.27B
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- LS
- Currency
- EUR
Dexcom, Inc. A0D9T1:LS stock context
This page tracks Dexcom, Inc.'s A0D9T1:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A0D9T1:LS. A0D9T1:LS is the stock-level entry point for investors researching Dexcom, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Dexcom, Inc. (Ticker: DXCM) is a public company based in America, specializing in continuous glucose monitoring systems for diabetes management. With a market capitalization of approximately $27.6 billion, Dexcom is recognized for its innovative technology that helps improve the lives of individuals with diabetes. The company focuses on providing real-time glucose data to empower users in their health management.
Latest news from Dexcom, Inc.
Dexcom Reports Second Quarter 2026 Financial Results
July 30, 2026
Dexcom Announced as First Participant Selected for FDA's TEMPO Digital Health Devices Pilot Program
July 22, 2026
Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes
July 13, 2026
Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern Time
July 9, 2026
Dexcom Further Advances Vision of Glucose Biosensing for All
June 23, 2026
Dexcom, Inc. earnings calls
DexCom, Inc. (DXCM) Q2 2026 Earnings Call
July 30, 2026 · Replay with transcript and chapters
DexCom, Inc. (DXCM) Q1 2026 Earnings Call
April 30, 2026 · Replay with transcript and chapters
DexCom, Inc. (DXCM) Q4 2025 Earnings Call
February 12, 2026 · Replay with transcript and chapters
DexCom, Inc. (DXCM) Q3 2025 Earnings Call
October 30, 2025 · Replay with transcript and chapters
DexCom, Inc. (DXCM) Q2 2025 Earnings Call
July 30, 2025 · Replay with transcript and chapters
DexCom, Inc. (DXCM) Q1 2025 Earnings Call
May 1, 2025 · Replay with transcript and chapters
Research Dexcom, Inc.
Dexcom, Inc. investor report
Review AI stock analysis and investor report context for A0D9T1:LS.
Dexcom, Inc. company profile
View the public company page for Dexcom, Inc. on 6ix.
Dexcom, Inc. news
Read company news and market updates connected to Dexcom, Inc..
Dexcom, Inc. investor events
Find investor webinars, events, and replay context for Dexcom, Inc..
Alternate listings
DXCM:NASDAQ
US · USD
Alternate listing for Dexcom, Inc.; the primary context on this page is A0D9T1:LS.
DC4:GETTEX
DE · EUR
Alternate listing for Dexcom, Inc.; the primary context on this page is A0D9T1:LS.
A0D9T1:LSX
DE · EUR
Alternate listing for Dexcom, Inc.; the primary context on this page is A0D9T1:LS.
DC4:TRADEGATE
DE · EUR
Alternate listing for Dexcom, Inc.; the primary context on this page is A0D9T1:LS.
DXCM:BMV
MX · MXN
Alternate listing for Dexcom, Inc.; the primary context on this page is A0D9T1:LS.
DC4:DUS
DE · EUR
Alternate listing for Dexcom, Inc.; the primary context on this page is A0D9T1:LS.
D1EX34:BMFBOVESPA
BR · BRL
Alternate listing for Dexcom, Inc.; the primary context on this page is A0D9T1:LS.
DC4:FWB
DE · EUR
Alternate listing for Dexcom, Inc.; the primary context on this page is A0D9T1:LS.
DXCM:BOATS
US · USD
Alternate listing for Dexcom, Inc.; the primary context on this page is A0D9T1:LS.
1DXCM:MIL
IT · EUR
Alternate listing for Dexcom, Inc.; the primary context on this page is A0D9T1:LS.
0A4M:LSE
GB · USD
Alternate listing for Dexcom, Inc.; the primary context on this page is A0D9T1:LS.
DC4:MUN
DE · EUR
Alternate listing for Dexcom, Inc.; the primary context on this page is A0D9T1:LS.